🇪🇺 Aclidinium bromide & formoterol fumarate in European Union

EMA authorised Aclidinium bromide & formoterol fumarate on 19 November 2014

Marketing authorisation

EMA — authorised 19 November 2014

  • Application: EMEA/H/C/003745
  • Marketing authorisation holder: Covis Pharma Europe B.V.
  • Local brand name: Duaklir Genuair
  • Indication: Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
  • Status: approved

Read official source →

Other Respiratory / Pulmonology approved in European Union

Frequently asked questions

Is Aclidinium bromide & formoterol fumarate approved in European Union?

Yes. EMA authorised it on 19 November 2014.

Who is the marketing authorisation holder for Aclidinium bromide & formoterol fumarate in European Union?

Covis Pharma Europe B.V. holds the EU marketing authorisation.